LONG-TERM RESULTS OF A PHASE II TRIAL OF ULTRASOUND-GUIDED RADIOACTIVE IMPLANTATION OF THE PROSTATE FOR DEFINITIVE MANAGEMENT OF LOCALIZED ADENOCARCINOMA OF THE PROSTATE (RTOG 98-05)
LONG-TERM RESULTS OF A PHASE II TRIAL OF ULTRASOUND-GUIDED RADIOACTIVE IMPLANTATION OF THE PROSTATE FOR DEFINITIVE MANAGEMENT OF LOCALIZED ADENOCARCINOMA OF THE PROSTATE (RTOG 98-05)
复制标题
DOI：
10.1016/j.ijrobp.2010.05.056
复制
发表时间：
2011-09-01
影响因子：
7
通讯作者：
Sandler, Howard
中科院分区：
文献类型：
--
作者：
Lawton, Colleen A.;Hunt, Daniel;Sandler, Howard
目的：评价经直肠超声引导下经直肠前列腺永久性放射性粒子植入治疗器官受限前列腺癌的远期疗效。方法和材料：本研究的患者均经组织学证实，前列腺癌临床分期为T1b、T1c或T2a；无结节或转移性疾病；前列腺癌患者的前列腺特异性抗原水平均为T1b、T1c或T2a。
Purpose: To evaluate the long-term effectiveness of transrectal ultrasound-guided permanent radioactive I-125 implantation of the prostate for organ confined adenocarcinoma of the prostate compared with historical data of prostatectomy and external beam radiotherapy within a cooperative group setting.Methods and Materials: Patients accrued to this study had histologically confirmed, locally confined adenocarcinoma of the prostate clinical stage T1b, T1c, or T2a; no nodal or metastatic disease; prostate-specific antigen level of